spironolactone has been researched along with Hepatic Veno Occlusive Disease in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with multiple myeloma undergoing ABMT developed classic features of hepatic VOD." | 1.30 | Serum tumor necrosis factor for monitoring response of hepatic veno-occlusive disease to pentoxiphyllin--a case report. ( Advani, SH; Anand, M; Gopal, R; Kapoor, G; Kulkarni, S; Nadkarni, JS; Parikh, PM; Saikia, TK; Sastry, PS, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parikh, PM | 1 |
| Advani, SH | 1 |
| Nadkarni, JS | 1 |
| Kulkarni, S | 1 |
| Kapoor, G | 1 |
| Sastry, PS | 1 |
| Anand, M | 1 |
| Saikia, TK | 1 |
| Gopal, R | 1 |
1 other study available for spironolactone and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Serum tumor necrosis factor for monitoring response of hepatic veno-occlusive disease to pentoxiphyllin--a case report.
Topics: Adult; Bone Marrow Transplantation; Dopamine; Hepatic Veno-Occlusive Disease; Humans; Male; Multiple | 1997 |